Abstract
A variety of soluble factors have been described which regulate the growth and differentiation of human B lymphocytes in vitro. Several of these factors were orginally recognized by their activity in assays of B cell function, for example IL-4, BSF-2, and BCGF.1–4 In contrast, we have been studying the effects on B cell function of three factors originally described to influence the function of cell types distinct from B cells. These three factors are Transforming Growth Factor-beta (TGF-ß), orginally described to induce certain adherent non-neoplastic cells to express a transformed phenotype and to undergo anchorage independent growth5; interleukin-2 (IL-2), first recognized to promote the growth of T lymphocytes6; and Tumor necrosis factors, first identified by their cytotoxic or cytostatic effects against certain tumor cell lines7. Each of these factors have been found to have significant regulatory effects on the growth and differentiation of human B cells in vitro.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
W.E. Paul, and J. Ohara, B-cell stimulatory factor-1/interleukin 4. Annu. Rev. Immunol 4:429 (1987).
T. Kishimoto, T. Hirano, H. Kikutani, and A. Muraguchi, Delineation of human B cell differentiation: immunological and molecular characterization of human B cell differentiation factor (BSF-2). Adv. Exp. Med. Biol 213:177 (1987).
J.L. Butler, A. Muraguchi, H.C. Lane, and A.S. Fauci, Development of a human T-T cell hybridoma secreting B cell growth factor. J. Exp. Med 157:60 (1983).
J.L. Ambrus, Jr., C.H. Jurgensen, E.J. Brown, and A.S. Fauci, Purification to homogeneity of a high molecular weight human B cell growth factor, demonstration of specific binding to activated B cells, and development of a monoclonal antibody to the factor. J. Exp. Med 162:1319 (1985).
D.A. Morgan, F.W. Ruscetti, and R.C. Gallo, Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193: 1007 (1976).
E.A. Carswell, L.J. Old, R.L. Kassel, S. Green, N. Fiore, and B. Williamson, an endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666 (1975).
A.B. Roberts, C.A. Frolik, M.A. Anzano, and M.B. Sporn, Transforming growth factors from neoplastic and nonneoplastic tissues. Fed. Proc 42:2621 (1983).
R.K. Assoian, A. Komoriya, C.A. Meyers, and M.B. Sporn, Transforming growth factor-ß in human platelets: identification of a major storage site, purification, and characterization. J. Biol. Chem 258:7155 (1983).
C.A. Frolik, L.L. Dart, C.A. Meyers, D.M. Smith, and M.B. Sporn, Purification and initial characterization of a type ß transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA 80:3676 (1983).
A. Roberts, M. Anzano, C. Meyers, J. Wideman, R. Blacher, Y.E. Pan, S. Stein, S.R. Lehrman, J.M. Smith, L.C. Lamb, and M.B. Sporn, Purification and properties of a type ß transforming growth factor from bovine kidney. Biochemistry 22: 5692 (1983).
R. Derynck, J.A. Jarrett, E.Y. Chen, D.H. Eaton, J.R. Bell, R.K. Assoian, A.B. Roberts, M.B. Sporn, and D.V. Geoddel, Human transforming growth factor-ß complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701 (1985).
S. Cheifetz, J.A. Weatherbee, M.L.-S. Tsang, J.K. Anderson, J.E. Mole, R. Lucas, and J. Massagué, The transforming growth factor-ß system, a complex pattern of cross-reactive ligands and receptors. Cell. 48: 409 (1987).
P.R. Seyedin, P.R. Segarini, D.M. Rosen, A.Y. Thompson, H. Bentz, and J. Graycor, Cartilage inducing factor-ß is a unique protein structurally and functionally related to transforming growth factor-ß. J. Biol. Chem 262:1946 (1987).
A.B. Roberts, and M.B. Sporn, Transforming growth factor-ß. Adv. Cancer Res 1988 in press.
J.H. Kehrl, L.M. Wakefield, A.B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M.B. Sporn, and A.S. Fauci, Production of transforming growth factor-ß by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med 163:1037 (1986).
J.H. Kehrl, A.B. Roberts, L.M. Wakefield, S. Jakowlew, M.B. Sporn, and A.S.Fauci, Transforming growth factor-ß is an important immunomodulatory protein for human B lymphocytes. J. Immunol 137:3855 (1987).
A.H. Rook, J.H. Kehrl, L.M. Wakefield, A.B. Roberts, M.B. Sporn, D.B. Burlington, H.C. Lane, and A.S. Fauci, Effects of transforming growth factor-ß on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol 136:3916 (1986).
G. Lee, L.R. Elingsworth, S. Gillis, R. Wall, and P.W. Kincade, ß-transforming growth factors are potential regulators of B lymphopoiesis. J. Exp. Med 166:1290 (1987).
G.E. Ranges, I.S. Figari, T. Espevik, and M.A. Palladino, Jr., Inhibition of cytotoxic T cell development by transforming growth factor ß and reversal by recombinant tumor necrosis factor a. J. Exp. Med 166:991 (1987).
H.K. Blomhoff, E. Smeland, A.S. Mustafa, T. Godai, and R. Ohlsson, Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type ß, in cells of the B cell lineage, Eur. J. Immunol 17:299 (1987).
D.A. Lawrence, R. Pircher, C. Kryceve-Martinerie, and P. Jullien, Normal embryo fibroblasts release transforming growth factors in a latent form. J. Cell. Physiol 121:184 (1984).
R. Pircher, D.A. Lawrence, and P. Jullien, Latent ß-transforming growth factor in non-transformed and Kirsten sarcoma virus-transformed normal rat kidney cells. Cancer Res 44: 5538 (1984).
D.A. Lawrence, R. Pircher, and P. Jullien, Conversion of a high molecular weight latent ß-TGF from chicken embryo fibroblasts into a low molecular weight active ß-TGF under acidic conditions. Biochem. Bionhvs. Res. Comm 133:1026 (1985).
D. Pennica, G.E. Nedwin, J.S. Hayflick, P.H. Seeburg, R. Derynck, M.A. Palladino, W.J. Kohr, B.B. aggarwal, and D.V. Goeddel, Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312: 724 (1984).
P.W. Gray, B.B. Aggarwal, C.V. Benton, T.S. Bringman, W.J. Henzel, J.A. Jarrett, D.W. Leung, B. Moffat, P. Ng, L.P. Svedersky, M.A. Palladino, and G.E. Nedwin, Cloning and expression of cDNa for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 312: 721 (1984).
B. Beutler, A. Cerami, Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320: 584 (1986).
R.J.M. Falkoff, J.L. Bulter, C.A. Dinarello, and A.S. Fauci, Direct effects of amonoclonal B cell differentiation factor and of purified interleukinn 1 on B cell differentiation. J. Immunol 133:692 (1986).
M.K. Hoffmann, S. Koenig, R.S. Mittler, H.F. Oettgen, P. Ralph, C. Galanos, and U. Hammerling, Macrophge factor controlling differentiation of B cells. J. Immunol 122:497 (1979).
M.K. Hoffmann, S. Green, L.J. Old, and H.F. Oettgen, Serum containing endotoxin-induced tumor necrosis factor substitutes for helper T cells. Nature. 263: 416 (1976).
A. Muraguchi, and A.S. Fauci, Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF). J. Immunol 129:1104 (1982).
J.H. Kehrl, A. Miller, and A.S. Fauci, Effect of tumor necrosis factor a on mitogen-activated human B cells. J. Exp. Med 166:786 (1987).
J.H. Kehrl, M. Alvarez-Mon, G.A. Delsing, and A.S. Fauci, Lymphotoxin is an important T cell-derived growth factor for human B cells. Science 238: 1144 (1987).
B.B. Aggarwal, T.E. Eessalu, P.E. Hass, Characterization of receptors for human tumour necrosis factor and their regulation by y-IFN. Nature 318: 665 (1985).
P. Scheurich, U. Ucer, M. Kronke, and K. Pfizenmaier, Quantification and characterization of high affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int. J. Cancer 38:127 (1986).
A.A. Creasey, R. Yamamoto, and C.R. Vih, A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. Proc. Natl.Acad. Sci. USA 84:3293 (1987).
A. Muraguchi, J.H. Kehrl, D.L. Longo, D.J. Volkman, and A.S. Fauci, Tac expression on activated B cells and on a human T-cell leukemia-infected B-cell line. J. Exp. Med 161:181 (1985).
M. Tsudo, T. Uchiyama, and H. Uchino, Expression of Tac antigen on activated normal human B cells. J. Exp. Med 160:602 (1984).
Le thi Bich-thuy and A.S. Fauci, Direct effect of interluekin 2 on the differentiation of human B cells which have not been preactivated in vitro. Eur. J. Immunol 15:1075 (1985).
M. Sharon, R.D. Klausner, B.R. Cullen, R. Chizzonite, and W.J. Leonard, Novel IL-2 receptor subunit detected by cross-linking under high affiity conditions. Science 234: 859 (1986).
M. Tsudo, R.W. Kozak, C.K. Goldman, and T.A. Waldmann, Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc. Natl. Acad. Sci. USA 83:9694 (1986).
K. Teshigawara, H. Wang, K. Kato, and K.A. Smith, Interleukin 2 high-affinity receptor expression requires two distinct binding protiens. J. Exp. Med 165:223 (1987).
R.J. Robb, C.M. Rusk, J. Yodoi, W.C. Greene, An interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high affinity receptors. Proc. Natl. Acad. Sci. USA 84:2002 (1987).
M. Dukovich, Y. Wano, Le thi Bich-Thuy, P. Katz, B.R. Cullen, J.H. Kehrl, and W.C. Greene, Identification of a second human interluekin-2 binding protein and its role in the assembly of the high affinity IL-2 receptor. Nature 327: 518 (1987).
Le thi Bich-Thuy, M. Dukovich, N.J. Peffer, A.S. Fauci, J.H. Kehrl, and W.C. Greene, Direct activation of human T cells by IL-2: the role of an IL-2 receptor distinct from the Tac protein. J. Immunol 239:1550 (1987).
P. Ralph, O. Saiki, D.H. Maurer, and K. Welte, IgM and IgG secretion in human B cell liens regulted by B cell-inducing factors (BIF) and phorbol ester. Immunol. Letter 7:17 (1983).
P. Ralph, G. Jeong, K. Welte, R. Mertelsmann, H. Rabin, L.E. Henderson, L.M. Souza, T.C. Boone, and R.J. Robb, Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL-2. J. Immunol 133:2442 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kehrl, J.H., Fauci, A.S. (1989). Alternative Cytokines in the Immunoregulation of the Human B Cell Cycle. In: Gupta, S., Paul, W.E. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation II. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5803-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5803-0_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5805-4
Online ISBN: 978-1-4757-5803-0
eBook Packages: Springer Book Archive